Research
Leveraging psychedelic neuroscience to boost human creativity using artificial intelligence.
Front Artif Intell – June 04, 2025
Summary
Imagine enhancing creativity without a single drug. Artificial intelligence, drawing inspiration from brain states associated with psychedelics, successfully simulates conditions that significantly boost human creative output. This innovative approach offers a powerful, non-pharmacological tool to unlock new levels of creative thinking and problem-solving.
Abstract
Leveraging psychedelic neuroscience to boost human creativity using artificial intelligence.
The Effect of Yoga on Cancer-Related Fatigue and Quality of Life Among Racially and Ethnically Diverse Cancer Survivors: A Secondary Data Analysis.
Journal of integrative and complementary medicine – June 04, 2025
Summary
Yoga practice shows promising benefits for diverse cancer survivors, helping reduce fatigue and improve quality of life. A 4-week mindfulness-based yoga program combining gentle movement, meditation, and breathing techniques helped participants feel better physically and emotionally. Among diverse participants, 86% found the program beneficial for managing symptoms, with notable improvements in physical well-being and fatigue reduction.
Abstract
Introduction: Survivors from racially and ethnically diverse backgrounds tend to experience cancer-related fatigue (CRF) at higher rates than non-H...
Brief Interactive Virtual Reality Mindfulness Training with Real-Time Biofeedback for Anxiety Reduction: A Pilot Study.
Applied psychophysiology and biofeedback – June 04, 2025
Summary
A mere five minutes in virtual reality can significantly reduce anxiety. An innovative brief mindfulness intervention used interactive virtual reality with real-time biofeedback, dynamically adjusting the virtual environment based on heart rate variability. This powerful approach markedly improved mindfulness and reduced anxiety, showing greater physiological benefits than traditional methods. It highlights VR's potential as a powerful tool for well-being.
Abstract
Recent advancements in virtual reality (VR)-enhanced mindfulness training have demonstrated efficacy in reducing anxiety, particularly among novice...
Minding the Body: A Meta-analysis of the Effects of Mindfulness Meditation Training on Self-reported Interoception.
Research square – June 04, 2025
Summary
Mindfulness meditation does more than calm the mind - it enhances our ability to sense internal bodily signals. Analysis of 29 studies shows that mindfulness training significantly improves body awareness, particularly through structured programs. These improvements correlate with reduced psychological distress, suggesting that better mind-body connection supports mental wellbeing.
Abstract
Mindfulness meditation training may cultivate interoceptive awareness and provide therapeutic benefit when implemented within mental and physical h...
Modulation of ER Stress and Inflammation by S-Ketamine, R-Ketamine, and Their Metabolites in Human Microglial Cells: Insights into Novel Targets for Depression Therapy.
Cells – June 03, 2025
Summary
Recent breakthroughs show ketamine and its variants can fight depression by reducing cellular stress and inflammation in brain immune cells. Both forms of ketamine and their metabolites decrease key stress proteins (CHOP and GRP78) while lowering inflammatory signals. This suggests new ways to treat resistant depression with fewer side effects than current antidepressants.
Abstract
Despite affecting millions worldwide, major depressive disorder (MDD) remains a therapeutic challenge, with approximately one-third of patients fai...
Effects of Psilocybin on Mouse Brain Microstructure.
AJNR. American journal of neuroradiology – June 03, 2025
Summary
Psilocybin, the active compound in magic mushrooms, creates measurable changes in brain structure that last for days after treatment. Scientists tracked these changes in mice using advanced brain imaging, revealing increased connectivity in areas controlling complex thinking and altered tissue structure in regions involved in memory and visual processing. These physical brain changes may explain psilocybin's promising effects on depression.
Abstract
There is surging interest in the therapeutic potential of psychedelic compounds like psilocybin in the treatment of psychiatric illnesses like majo...
Decoupling of motor cortex to movement in Parkinson's dyskinesia rescued by sub-anaesthetic ketamine.
Brain : a journal of neurology – June 03, 2025
Summary
Ketamine shows promise in treating movement complications from Parkinson's medication. Using in vivo electrophysiology in rats, researchers found that motor cortex activity becomes disconnected from actual movements during levodopa-induced dyskinesia. Sub-anesthetic ketamine helped restore this connection by reorganizing neural population states, reducing unwanted movements without disrupting normal motor function.
Abstract
Gamma-band and single-unit neural activity in primary motor cortex are involved in the control of movement. This activity is disrupted in Parkinson...
An international Delphi consensus for reporting of setting in psychedelic clinical trials.
Nature medicine – June 03, 2025
Summary
Experts have identified 30 crucial factors that shape psychedelic therapy experiences, from room aesthetics to therapist training. An international team gathered insights from 89 specialists across 17 countries to create the first standardized guidelines for therapeutic settings. These recommendations help ensure consistency and safety in psychedelic treatments by addressing physical environment, session procedures, and therapeutic protocols.
Abstract
Psychedelic substances exhibit complex interactions with the 'set and setting' of use, that is, the mental state of the user and the environment in...
The psychedelic-peptide paradox: a hormetic hypothesis.
Compr Psychoneuroendocrinol – June 02, 2025
Summary
Powerful compounds can yield unexpected benefits at very low doses. A new theory proposes that psychedelics, despite their potent effects, may operate through a "hormetic" mechanism. This means tiny amounts could trigger positive biological responses, akin to how exercise strengthens the body. The concept suggests specific peptides might mediate these beneficial actions, offering a fresh perspective on their therapeutic potential. This highlights the subtle, positive ways these substances interact with biology.
Abstract
The psychedelic-peptide paradox: a hormetic hypothesis.
Correction: Effectiveness of Neurofeedback-Assisted and Conventional 6-Week Web-Based Mindfulness Interventions on Mental Health of Chinese Nursing Students: Randomized Controlled Trial.
Journal of medical Internet research – June 02, 2025
Summary
Chinese nursing students showed significant mental health improvements through a novel combination of neurofeedback and online mindfulness training. Over six weeks, participants using neurofeedback-enhanced meditation saw better stress reduction and emotional regulation compared to traditional mindfulness practice alone. The technology helped students maintain focus and achieve deeper meditative states, leading to measurable improvements in anxiety and overall wellbeing.
Abstract
[This corrects the article DOI: 10.2196/71741.].
MDMA-Assisted Treatment for PTSD, Anxiety, and Depression: A Visualized Literature Analysis over 30 Years.
Current medicinal chemistry – June 02, 2025
Summary
Over three decades of research reveals MDMA-assisted therapy shows remarkable promise in treating PTSD, anxiety, and depression. Analysis of 30 years of scientific literature shows a dramatic shift from studying MDMA's risks to exploring its therapeutic benefits. The U.S. leads research efforts, with breakthrough results demonstrating MDMA's potential to help patients process trauma and emotional distress in controlled therapeutic settings.
Abstract
The incidence of psychiatric disorders, such as post-traumatic stress disorder (PTSD), anxiety, and depression, has been steadily increasing, while...
Ketamine improves anhedonic phenotypes across species: Translational evidence from the Probabilistic Reward Task
medRxiv Preprint Server – June 02, 2025
Summary
Remarkably, ketamine's ability to boost mood in severe depression may stem from its impact on how we experience pleasure. Researchers investigated if a single, low dose of ketamine could improve reward responsiveness in both patients with treatment-resistant depression and stressed rats. Using functionally identical tasks, a significant enhancement in reward processing was observed across both species. This robustly demonstrates that ketamine effectively restores the capacity for reward, offering a powerful new approach for those struggling with anhedonia.
Abstract
Background Ketamine is increasingly used as a therapeutic option for treatment-resistant depression (TRD) due to its rapid antidepressant propertie...
Cardiovascular Effects of Non-Selective Monoamine Oxidase Inhibitors and Intranasal Esketamine Combination in Depression - A Quasi-Experimental Design with Bayesian Analyses.
Pharmacopsychiatry – June 02, 2025
Summary
Combining two powerful antidepressant treatments shows promising safety results. A recent analysis of 193 treatment sessions revealed that intranasal esketamine can be safely combined with certain antidepressants, showing only minor, clinically insignificant changes in blood pressure and heart rate. This finding opens new possibilities for patients with treatment-resistant depression who need multiple medication options.
Abstract
Ketamine and esketamine (ESK) offer new treatment options for resistant depression. Unlike traditional antidepressants, they can be used in combina...
Enhancing interoceptive awareness in chronic pain and opioid misuse via mindfulness-oriented recovery enhancement.
Drug and alcohol dependence – June 02, 2025
Summary
Many individuals with substance use issues report altered body awareness. For those with chronic pain, lower interoceptive awareness was specifically linked to higher opioid misuse. A Mindfulness-based program significantly enhanced interoception, successfully reducing opioid misuse over nine months. This suggests that boosting interoceptive awareness is a promising strategy for managing chronic pain and addressing opioid misuse.
Abstract
Individuals with substance use disorders often report altered interoceptive awareness of internal bodily signals. However, it is unclear whether th...
"A period of limbo": The experience of being a male family member of a person in a prolonged disorder of consciousness (PDoC); an Interpretative Phenomenological Analysis.
Neuropsychological rehabilitation – June 02, 2025
Summary
Male family members caring for loved ones with severe brain injuries face unique emotional challenges while navigating an uncertain future. Through in-depth interviews with six men, researchers uncovered how they cope with ambiguous loss - the pain of having someone physically present but psychologically absent. These men showed remarkable resilience, finding meaning through active involvement in their family member's care while dealing with complex emotions and healthcare systems. Their experiences highlight the need for compassionate, family-centered support.
Abstract
Prolonged Disorders of Consciousness (PDoC) are complex conditions characterised by sustained consciousness impairment lasting over four weeks foll...
Exploring the Therapeutic Potential of Psilocybin and Ketamine in Major Depressive Disorder including Treatment-Resistant Depression: A Narrative Review
Biuletyn Głównej Biblioteki Lekarskiej – June 01, 2025
Summary
Novel medicine offers hope for Major depressive disorder (MDD) and Treatment-resistant depression. Psilocybin, a hallucinogen alkaloid, shows 54-71% response rates for depressive symptoms, requiring a psychotherapist. Ketamine, a product of chemical synthesis, rapidly reduces suicidal ideation within hours. Both agents, influencing neurotransmitter receptors, represent a paradigm shift in psychiatry and clinical psychology. Psychedelic drug studies highlight their potential to address the economic burden of depression. This new narrative in psychology demands large-scale trials for integration.
Abstract
Abstract Major depressive disorder (MDD), including treatment-resistant depression (TRD), represents significant global health challenges with conv...
Acute effects of psilocybin on attention and executive functioning in healthy volunteers: a systematic review and multilevel meta-analysis.
Psychopharmacology – June 01, 2025
Summary
Psilocybin's effects on cognitive performance reveal an intriguing pattern: while the psychedelic temporarily slows reaction time, it largely preserves accuracy in mental tasks. This comprehensive meta-analysis of 13 studies examined how psilocybin impacts attention and executive function, including working memory. Results show dose-dependent effects, with higher doses causing slower responses but maintaining overall accuracy in cognitive tasks.
Abstract
Psilocybin shows promise for treating neuropsychiatric disorders. However, insight into its acute effects on cognition is lacking. Given the signif...
The associations and effects of mindfulness on anger and aggression: A meta-analytic review.
Clinical psychology review – June 01, 2025
Summary
Mindfulness can significantly reduce anger and aggression. An extensive analysis of 118 studies revealed that individuals with higher dispositional mindfulness reported lower anger (23%) and aggression (19%). Mindfulness-based interventions demonstrated medium effects, decreasing anger by 48% and aggression by 61% compared to control groups. These effects were particularly pronounced in Asia and across various populations, including clinical and healthy adults. The findings underscore mindfulness training's potential for effective emotion regulation, emphasizing the importance of robust control groups in future investigations.
Abstract
Dispositional mindfulness and mindfulness-based interventions have been linked to emotion regulation and may reduce anger and aggression. The prese...
Efficacy and safety of psilocybin for the treatment of substance use disorders: A systematic review.
Neuroscience and biobehavioral reviews – June 01, 2025
Summary
Psilocybin-assisted psychotherapy shows remarkable promise in addiction treatment, with some studies reporting up to 80% success in helping people overcome substance use disorders. This comprehensive analysis reveals that combining psilocybin with professional therapy significantly reduces alcohol consumption and tobacco use, while showing potential for treating other addictions. The treatment appears safe and effective.
Abstract
Psilocybin, a serotonergic psychedelic, may have therapeutic benefits for Substance Use Disorders (SUDs), but its overall efficacy and safety remai...
Etomidate versus ketamine for in-hospital rapid sequence intubation: a systematic review and meta-analysis.
European journal of emergency medicine : official journal of the European Society for Emergency Medicine – June 01, 2025
Summary
When seconds count in emergency care, choosing the right medication for rapid sequence intubation matters. A comprehensive analysis of nearly 24,000 critically ill patients revealed that both etomidate and ketamine are equally effective for emergency breathing tube placement. While etomidate showed lower need for blood pressure support, ketamine had less impact on hormone function. This finding gives doctors confidence in using either medication based on individual patient needs.
Abstract
Rapid sequence intubation (RSI) is a critical procedure in emergency and intensive care settings. Etomidate has been favored for its hemodynamic st...
Psilocybin-enhanced fear extinction linked to bidirectional modulation of cortical ensembles.
Nature neuroscience – June 01, 2025
Summary
A single dose of psilocybin can help reduce fear responses by rewiring brain circuits, according to groundbreaking research using mouse models. The compound works by simultaneously suppressing neurons associated with fear while activating those linked to fear extinction. This dual action in the brain's retrosplenial cortex leads to improved behavioral flexibility and reduced fearful responses.
Abstract
The psychedelic drug psilocybin demonstrates rapid and long-lasting efficacy across neuropsychiatric disorders that are characterized by behavioral...
Psilocybin's lasting action requires pyramidal cell types and 5-HT2A receptors.
Nature – June 01, 2025
Summary
A single dose of psilocybin can create lasting changes in specific brain cells, offering hope for stress-related mental health treatments. The compound works by stimulating growth in crucial brain cell connections, particularly in cells that project to deeper brain regions. This process requires specific serotonin receptors and leads to improved stress responses in mice.
Abstract
Psilocybin is a serotonergic psychedelic with therapeutic potential for treating mental illnesses1-4. At the cellular level, psychedelics induce st...
Comparison between pediatric and adult acute natural cannabinoids toxicity: A 5-year retrospective study with special consideration of acute synthetic cannabinoids toxicity.
Toxicology reports – June 01, 2025
Summary
Acute natural cannabinoid toxicity is significantly more prevalent than synthetic cannabinoids, with 64% of cases involving children (n=68) compared to 36% in adults (n=38). Children exhibited higher rates of impaired consciousness and bradypnea, while adults showed low oxygen saturation and tachycardia. Delay in medical intervention predicted complications in children, with adjusted odds ratios of 1.393 for delay time and 4.139 for potassium levels. Only four cases of acute synthetic cannabinoid toxicity were noted, primarily presenting with severe symptoms like seizures and hypoxemia.
Abstract
Acute cannabinoids toxicity is an alarming toxicological problem. The current study aimed to compare children and adults with acute natural cannabi...
Minorities' Diminished Psychedelic Returns: Income and Educations Impact on Whites, Blacks, Hispanics, and Asians.
Journal of racial and ethnic health disparities – June 01, 2025
Summary
Income and education levels significantly influence how different racial groups respond to psychedelics for mental health benefits. While white individuals show reduced psychological distress with psychedelic use, minorities experience diminished returns - even at higher socioeconomic levels. Notably, educated, high-income Asian users reported increased distress, highlighting how ethnicity and inequality shape therapeutic outcomes.
Abstract
Growing evidence suggests that the race and ethnic minority population may experience fewer protective effects of psychedelics on mental health. Th...
Exploring Gender-Themed Lysergic Acid Diethylamide Experiences: A Subreddit Analysis.
Psychedelic medicine (New Rochelle, N.Y.) – June 01, 2025
Summary
Intriguingly, some people find LSD helps clarify their gender identity. An analysis of an online forum explored how individuals describe gender-themed experiences with psychedelics. Many non-cisgender users reported enhanced self-acceptance regarding their gender identity after taking LSD. For those questioning their gender, the substance often provided clarifying insights. Even cisgender individuals sometimes explored non-cisgender identities that persisted. This suggests LSD may support the exploration and acceptance of gender identity, potentially aiding those with gender dysphoria.
Abstract
Gender-themed lysergic acid diethylamide (LSD) experiences have been documented anecdotally but not yet studied systematically. This study aimed to...
The Effect of Ketamine-Assisted Group Therapy on Treatment-Resistant Mental Health Conditions in Firefighters: A Prospective Observational Case Series.
Journal of occupational and environmental medicine – June 01, 2025
Summary
Firefighters experiencing PTSD and depression found remarkable relief through an innovative combination of ketamine and group therapy. This groundbreaking treatment helped first responders return to work and daily life with significantly reduced symptoms. The 12-week program, blending psychedelic-assisted therapy with peer support, showed lasting benefits. Participants reported major improvements in anxiety and trauma symptoms that persisted six months after treatment, marking a promising advance in mental health care for emergency personnel.
Abstract
Firefighters display elevated risk for diagnoses of mental health illnesses. Psychedelic-assisted therapies show promise in the treatment of clinic...
The effect of mindfulness interventions on couple relationship satisfaction: A systematic review and meta-analysis.
Journal of consulting and clinical psychology – June 01, 2025
Summary
Mindfulness practices offer a tangible boost to romantic partnerships. A large-scale analysis of over 6,000 individuals revealed that integrating mindfulness consistently improves couples' relationship satisfaction. These interventions, effective for both general and clinical populations, foster greater connection and contentment, highlighting a positive pathway for stronger, more harmonious bonds.
Abstract
Mindfulness interventions (MIs) train nonjudgmental attention to present-moment experience and aim to improve mental health and well-being. The evi...
Analysis of drugs of abuse and contaminants in individuals under drug surveillance programs: A study in hair samples.
Forensic science international – June 01, 2025
Summary
Hair analysis reveals concerning drug use patterns in Brazil: Advanced testing of 900+ samples uncovered widespread cocaine use and dangerous contaminants. Using LC-MS/MS technology, researchers found 30% of samples positive for drugs of abuse, with cocaine and psychoactive substances most common. Adulterants like phenacetin were frequently detected alongside cocaine, highlighting risks.
Abstract
In this study, over 900 hair samples from individuals using drugs of abuse in São Paulo and Rio Grande do Sul, Brazil were analysed for classical d...
The Evolution of Do-It-Yourself Brain Hacking: From Fringe to Frontier.
Cureus – June 01, 2025
Summary
Remarkably, self-directed brain hacking, once niche, now influences mainstream healthcare. This biohacking evolution, driven by a desire for cognitive optimization, saw early users explore nootropics, microdosing, and transcranial stimulation. Such personal neuroenhancement efforts, leveraging neurotechnology, have inspired regulated digital therapeutics. As programmable cognition becomes a reality, medical stewardship is vital for safe and effective advancements.
Abstract
Do-it-yourself (DIY) brain hacking has evolved from fringe experimentation to a cultural and clinical phenomenon reshaping how individuals interact...
Qualitative Analysis of Views of Psychedelic-Assisted Therapy in Low-Income, Urban, Black Americans.
Psychedelic medicine (New Rochelle, N.Y.) – June 01, 2025
Summary
Many Black Americans show increasing openness to psychedelic-assisted therapy, despite historical healthcare mistrust. A qualitative investigation explored perceptions of psychedelics for therapy among low-income, urban Black Americans via focus groups. Findings revealed informed hesitation mixed with growing acceptance, emphasizing the need for trust, autonomy, and practical solutions like childcare and transport. Centering the needs of Black Americans and promoting diversity in therapy is crucial for improving access and quality of care.
Abstract
Black Americans are significantly underrepresented in psychedelic trials despite significant mental health disparities. Growing research suggests t...
Neural Electrical Correlates of Subjective Happiness.
Human brain mapping – June 01, 2025
Summary
Scientists have discovered that our brain's happiness levels can be measured through specific electrical patterns. Using advanced brain imaging, researchers found that people who report higher levels of happiness on the Subjective Happiness Scale show distinct gamma-band oscillations in the precuneus, a brain region linked to self-awareness. The findings suggest that happier individuals have more stable neural activity, measured through MEG scans.
Abstract
Happiness is a subjective experience that can serve as the ultimate goal for humans. A recent study that employed resting-state functional magnetic...
Treating narcolepsy-related nightmares with cognitive behavioural therapy and targeted lucidity reactivation: A pilot study.
Journal of sleep research – June 01, 2025
Summary
Nightmare frequency significantly decreased from an average of 8.38 to 2.25 per week in adults with narcolepsy after undergoing Cognitive Behavioural Therapy for Nightmares (CBT-N), with a large effect size of -0.97. The addition of targeted lucidity reactivation (TLR) enhanced lucid dreaming experiences among participants, leading to improved dream control. Participants also reported reductions in sleep paralysis and hypnagogic hallucinations. Overall, the treatment resulted in heightened self-efficacy in managing symptoms and decreased anxiety surrounding nightmares, suggesting promising therapeutic strategies for narcolepsy-related disturbances.
Abstract
Nightmares are a common symptom in narcolepsy that has not been targeted in prior clinical trials. This study investigated the efficacy of Cognitiv...
The Effects of an Online Yoga Nidra Meditation on Subjective Well-Being and Diurnal Salivary Cortisol: A Randomised Controlled Trial.
Stress and health : journal of the International Society for the Investigation of Stress – June 01, 2025
Summary
Engaging in just 11 minutes of Yoga Nidra meditation can significantly enhance psychological well-being, reducing depression and stress levels. In a randomized controlled trial with 362 participants, those practicing Yoga Nidra showed notable improvements in mental health compared to waitlist controls, with effect sizes ranging from 0.08 to 0.16. Additionally, regular practice led to lower cortisol levels and a healthier diurnal pattern. The longer 30-minute sessions further enhanced mindfulness and awareness, suggesting that even brief interventions can promote substantial health benefits.
Abstract
Yoga Nidra meditation has been increasingly examined in recent years for its potential to enhance psychological well-being. However, few studies ha...
Ayahuasca-inspired DMT/HAR formulation reduces brain differentiation between self and other faces.
NeuroImage – June 01, 2025
Summary
Psychedelics like ayahuasca can blur the line between self and other - now scientists know why. Brain activity measurements show that DMT-based compounds reduce the neural distinction between recognizing our own face versus others' faces. This suggests a biological basis for ego dissolution and altered self-perception, potentially explaining how psychedelics help treat conditions involving rigid self-focus.
Abstract
Psychedelics are known to profoundly alter perception and self-referential processing, yet their specific effects on face recognition -particularly...
Zebrafish embryo-larval testing reveals differential toxicity of new psychoactive substances.
Toxicology reports – June 01, 2025
Summary
Using zebrafish embryos as test subjects, researchers discovered that emerging recreational drugs have vastly different toxicity levels. While ketamine-like compounds showed minimal effects at early stages, synthetic cannabinoids caused severe developmental issues and high mortality rates. This finding helps explain why these substances pose such varying levels of risk to human health.
Abstract
New psychoactive substances (NPS) have emerged as a significant public health concern, with synthetic cannabinoid receptor agonists (SCRAs) and ket...
Expanding Ketamine Application for Treatment of Acute Suicidality in Long-Duration Spaceflight.
Aerospace medicine and human performance – June 01, 2025
Summary
Addressing acute suicidality in long-duration spaceflight is a critical challenge. A comprehensive literature review explored how ketamine, known for its rapid efficacy on Earth, could be a vital intervention for psychiatric emergencies in space. This analysis of 122 publications suggests ketamine offers a safe, multifaceted tool for Earth-independent medical operations, significantly enhancing behavioral health support for future spaceflight missions.
Abstract
The transition to exploration missions places a heightened risk on behavioral health in spaceflight. Although serious psychiatric emergencies durin...
Ketamine infusion for pain control in severely injured patients: Results of a randomized controlled trial.
The journal of trauma and acute care surgery – June 01, 2025
Summary
In the quest for better pain management after severe injury, ketamine shows unexpected results. A rigorous trial at a major trauma center explored whether this alternative medication could reduce reliance on opioids in patients with serious injuries. Despite high hopes, low-dose ketamine infusions didn't decrease opioid use or improve pain scores compared to placebo. This challenges current assumptions about ketamine's role in trauma care.
Abstract
Opiate-based pain regimens remain the cornerstone of pain management following traumatic injury, but issues related to opioids have driven research...
Intravenous Magnesium Sulfate as an Adjunct to Intravenous Ketamine for Acute Pain: A Case Series.
Journal of pain & palliative care pharmacotherapy – June 01, 2025
Summary
When combining magnesium sulfate with ketamine, doctors found a promising way to manage severe pain more effectively. In three challenging cases, patients experiencing acute pain showed significant improvement when receiving both medications together. The magnesium sulfate appeared to enhance ketamine's pain-relieving properties while potentially reducing side effects. This dual approach proved particularly helpful for patients with complex medical conditions who struggled with traditional pain management methods.
Abstract
Intravenous (IV) magnesium sulfate, a versatile electrolyte, plays a pivotal role across various medical domains. From cardiac care to obstetrics, ...
Rising incidence of recreational ketamine use: Clinical cases and management in emergency settings.
Toxicology reports – June 01, 2025
Summary
Emergency medicine data reveals a surge in ketamine-related incidents, particularly among young clubgoers. When mixed with alcohol or other drugs, this party drug can cause dangerous intoxication symptoms including hallucinations and heart problems. Regular use risks serious bladder damage. While current toxicological screening often misses ketamine, adding it to standard tests would help doctors better treat affected patients.
Abstract
The recreational use of ketamine has risen significantly in the Netherlands, particularly among young adults in nightlife settings. This trend has ...
The therapeutic effects of psychedelics for opioid use disorder: A systematic review of clinical studies.
Psychiatry research – June 01, 2025
Summary
Psychedelic compounds show promising potential in treating opioid use disorder, offering hope beyond traditional treatments. Studies reveal that substances like ketamine and ibogaine can significantly reduce withdrawal symptoms and cravings. While classic psychedelics like psilocybin and LSD demonstrate potential, the strongest evidence currently supports ketamine's effectiveness. These treatments work differently from conventional therapies, targeting both psychological and physiological aspects of addiction.
Abstract
Opioid-related overdose deaths have reached record high levels, and novel treatments for opioid use disorder (OUD) are needed. The three United Sta...
Association Between Receipt of Ketamine vs Etomidate for Emergency Tracheal Intubation and Symptoms of Posttraumatic Stress Disorder at 12 Months.
CHEST critical care – June 01, 2025
Summary
Receiving ketamine for emergent tracheal intubation is associated with significantly fewer symptoms of posttraumatic stress disorder (PTSD) at 12 months compared to etomidate. Among 141 critically ill patients, those given ketamine had a median PTSD score of 7 versus 14 for etomidate. Only 15.4% of ketamine patients met probable PTSD criteria, compared to 20.2% for etomidate. Reducing PTSD can also lessen associated anxiety, depression, and long-term cognitive impairment, offering a potential benefit during critical care.
Abstract
One of 3 patients in the ICU receiving mechanical ventilation demonstrates posttraumatic stress disorder (PTSD). A single dose of ketamine has been...
Pharmacological therapies for early and long-term recovery in disorders of consciousness: current knowledge and promising avenues.
Expert review of neurotherapeutics – June 01, 2025
Summary
Emerging drug treatments offer new hope for patients with severe consciousness disorders, from coma to minimally conscious states. Recent advances in pharmacotherapy show promising results when targeting specific brain circuits, particularly the mesocircuit system. Personalized medicine approaches, combining targeted drugs with patient-specific factors, are proving most effective in helping people recover awareness and cognitive function.
Abstract
Disorders of consciousness (DoC) are characterized by impaired arousal and/or awareness, ranging from coma to unresponsive wakefulness syndrome, mi...
Impact analysis of expanded access to ketamine for treatment-resistant depression.
Journal of comparative effectiveness research – June 01, 2025
Summary
Ketamine treatment could save the US healthcare system over $828 million annually while helping thousands more patients with severe depression. Using advanced simulation techniques, researchers found that expanding ketamine access would allow 75,000 more patients to receive care in the first year compared to traditional electroconvulsive therapy. The Markov model showed ketamine was equally effective but more cost-efficient for treatment-resistant depression, benefiting both patients and insurers.
Abstract
Aim: This study aimed to estimate the economic impacts of expanded access to ketamine relative to electroconvulsive therapy (ECT) by offering intra...
The effect of MDMA on anterior pituitary hormones: a secondary analysis of a randomized placebo-controlled trial.
Endocrine connections – June 01, 2025
Summary
MDMA, known for its therapeutic potential, dramatically increases stress hormones in the body - boosting ACTH levels by over 200% within two hours. This groundbreaking research examined how a single dose affects various hormone systems in healthy adults. Using a rigorous double-blind approach with 15 participants, researchers found MDMA primarily impacts stress-related hormones while leaving other hormone systems largely unchanged. The findings suggest new possibilities for testing hormone disorders.
Abstract
3,4-Methylenedioxymethamphetamine (MDMA), a psychoactive substance, has been proposed as a novel provocation test for oxytocin deficiency. Limited ...
COVID-19-Associated Cytotoxic Lesions of the Corpus Callosum in Chinese Patients: A Retrospective Study.
Brain and behavior – June 01, 2025
Summary
Brain inflammation linked to SARS-CoV-2 can affect the corpus callosum, a vital bridge between brain hemispheres. Chinese researchers found that patients with this rare inflammatory encephalopathy showed promising recovery when treated promptly. Advanced neuroimaging revealed distinct patterns in eight patients, with most experiencing fever before neurological symptoms. After treatment, seven patients showed significant improvement within two weeks.
Abstract
Cytotoxic lesions of the corpus callosum (CLOCCs) are a rare clinicoradiologic syndrome, exceptionally rare in association with coronavirus disease...
Perception of Pain in the Catheter Angiography Laboratory Among Children with Congenital Heart Disease.
Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir – June 01, 2025
Summary
Children with heart conditions experience varying levels of pain during cardiac procedures, even with anesthesia. In a revealing analysis of 24 young patients, researchers tracked pain responses during catheterization using skin conductance monitoring. Results showed significant pain variations during pre-procedure, local anesthesia, and vascular intervention phases. Higher doses of ketamine were linked to reduced post-procedure discomfort, especially when mothers were present. These insights help doctors better manage patient comfort.
Abstract
This study aimed to evaluate the level of pain caused by routine procedures during cardiac catheterization and explore ways to enhance patient comf...
Psilocybin increases emotional empathy in patients with major depression.
Molecular psychiatry – June 01, 2025
Summary
A single dose of psilocybin significantly boosted emotional empathy in people with depression, particularly their ability to connect with positive emotions in others. When combined with psychological support, the treatment helped participants better understand and share others' feelings for at least two weeks, compared to those who received a placebo. This improvement in social connection may help explain why psilocybin shows promise as a depression treatment.
Abstract
Empathy plays a crucial role in interpersonal relationships and mental health. It is decreased in a variety of psychiatric disorders including majo...
Measuring suicidal behavior in the era of rapid-acting antidepressants: A systematic review of ketamine studies.
Psychiatry research – June 01, 2025
Summary
Recent breakthroughs show ketamine can rapidly reduce suicidal thoughts in people with major depressive disorder. Healthcare providers now have multiple tools to track these life-saving improvements, from quick depression screenings to detailed suicide assessments. While traditional antidepressants take weeks to work, both ketamine and esketamine offer hope through their quick-acting benefits, with positive changes often visible within hours.
Abstract
Assessment measures for suicidal behavior range from depression scales to longer suicide-specific instruments. In this review, we systematically su...
Advanced and long-term meditation and the autonomic nervous system: A review and synthesis.
Neuroscience and biobehavioral reviews – June 01, 2025
Summary
Long-term meditators exhibit a fascinating interplay between the sympathetic and parasympathetic nervous systems, often achieving a state termed "relaxed alertness." In a comprehensive review of 200 studies, patterns emerged showing that advanced meditation practices can lead to significant heart rate variability changes. Specifically, very low and low-frequency spectral power peaks were observed, indicating enhanced cardiac resonance and respiratory coupling. By refining the understanding of these brain-body interactions, there is potential to enhance meditation training, possibly incorporating technology for even greater benefits.
Abstract
Meditation has become prominent in both clinical and non-clinical applications for its effects on psychological and physical well-being. Long-term ...
Ketamine in Neurocritical Care: New Potentials and Perspectives.
Cureus – June 01, 2025
Summary
Ketamine, once controversial in brain injury treatment, emerges as a game-changing medication in neurocritical care. This versatile drug offers unique benefits: it provides effective sedation while protecting brain cells from damage. Beyond its primary role, ketamine shows promising anticonvulsant properties and maintains stable blood pressure in critical patients, making it invaluable for neurological emergencies.
Abstract
Ketamine is an intravenous hypnotic anesthetic that acts primarily by inhibiting N-methyl-D-aspartate (NMDA) receptors, leading to a range of effec...